Walleye Capital
GILD icon

Walleye Capital’s Gilead Sciences GILD Stock Holding History

Walleye Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Sell
1,222
-149,745
-99% -$19.7M ﹤0.01% 3652
2026
Q1 		$21M Buy
150,967
+127,817
+552% +$17.9M 0.09% 179
2025
Q4 		$2.84M Buy
23,150
+8,383
+57% +$1.02M 0.01% 1580
2025
Q3 		$1.64M Sell
14,767
-1,817
-11% -$207K 0.01% 1726
2025
Q2 		$1.84M Buy
+16,584
New +$1.76M 0.01% 1580
2025
Q1 		– Sell
-5,404
Closed -$558K – 4559
2024
Q4 		$499K Sell
5,404
-8,382
-61% -$755K ﹤0.01% 2984
2024
Q3 		$1.16M Sell
13,786
-86,379
-86% -$6.59M ﹤0.01% 2505
2024
Q2 		$6.87M Buy
100,165
+99,490
+14,739% +$6.64M 0.01% 1039
2024
Q1 		$49.4K Buy
+675
New +$51.9K ﹤0.01% 4681
2021
Q1 		– Sell
-13,688
Closed -$797K – 1234
2020
Q4 		$797K Buy
+13,688
New +$826K 0.05% 345
2020
Q2 		– Sell
-380
Closed -$28K – 747
2020
Q1 		$28K Sell
380
-360
-49% -$24.9K 0.01% 734
2019
Q4 		$48K Sell
740
-29,989
-98% -$1.95M ﹤0.01% 1507
2019
Q3 		$1.95M Buy
30,729
+30,129
+5,022% +$1.97M 0.12% 230
2019
Q2 		$41K Buy
600
+110
+22% +$7.24K ﹤0.01% 1417
2019
Q1 		$32K Buy
+490
New +$32.6K 0.01% 1288

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Walleye Capital's GILD Position: Q2 2026 in Review

Walleye Capital reduced its Gilead Sciences (GILD) stake by 99% in Q2 2026, selling an estimated $19.7M and leaving 1,222 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #3652.

Walleye Capital first reported a position in GILD in Q1 2019 and has held it in 15 quarters since. The position peaked at $21M in Q1 2026. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Walleye Capital held 1,222 shares of Gilead Sciences worth $154K as of Q2 2026.
  • Walleye Capital sold 149,745 Gilead Sciences shares in Q2 2026, an estimated $19.7M.
  • Gilead Sciences made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3652 holding.
  • Walleye Capital first reported a position in Gilead Sciences in Q1 2019 and has held it in 15 quarters since.
  • Walleye Capital's Gilead Sciences position peaked at $21M in Q1 2026.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.